• Clinical and surgical gynaecological oncology
  • Purinergic signalling in normal endometrial cells, endometriosis and endometrial cancer
  • Selective treatment and immunotherapy in gynaecological cancer

Novel POLE pathogenic germline variant in a family with multiple primary tumors results in distinct mutational signatures

Castellsagué E, Li R, Aligue R, González S, Sanz J, Martin E, Velasco À, Capellá G, Stewart CJR, Vidal A, Majewski J, Rivera B, Polak P, Matias-Guiu X, Brunet J, Foulkes WD

HUMAN MUTATION. (ISSN/ISBN: 10597794).

2019

Orthoxenografts of testicular germ cell tumors demonstrate genomic changes associated with cisplatin resistance and identify PDMP as a re-sensitizing agent.

Piulats JM, Vidal A, García-Rodríguez FJ, Muñoz C, Nadal M, Moutinho C, Martínez-Iniesta M, Mora J, Figueras A, Guinó E, Padullés L, Aytés À, Molleví DG, Puertas S, Martínez-Fernández C, Castillo W, Juliachs M, Moreno V, Muñoz P, Stefanovic M, Pujana MA, Condom E, Esteller M, Germà JR, Capella G, Farré L, Morales A, Viñals F, García-Del-Muro X, Cerón J, Villanueva A

CLINICAL CANCER RESEARCH (ISSN/ISBN: 10780432)

2018

See full list

Descripción de nuevas dianas terapéuticas basadas en la glicosilación específica de las células madre del cáncer de mama

Ruth Rodriguez Barrueco (Investigador principal (IP)); Rodriguez Barrueco, Ruth (Investigador/a)

2019-01-01 - 2019-12-31

Breast cancer stem-like cells specific glycosylation as therapeutic target

Ruth Rodriguez Barrueco (Investigador principal (IP)); Rodriguez Barrueco, Ruth (Investigador/a)

Entitat finançadora:
  • CONTRATOS RAMON Y CAJAL
  • MINISTERIO DE ECONOMÍA, INDUSTRIA Y COMPETITIVIDAD

2018-04-01 - 2023-03-31

Universitat de Barcelona start-up

Rodriguez Barrueco, Ruth (Investigador/a)

2018-04-01 - 2023-03-31

Unravelling JNK regulatory networks implicated in autophagy induction in response to Sorafenib in endometrial cancer (EC)

Llobet Navas, David (Participante)

2018-03-01 - 2019-02-28

Estudio del efecto del sistema inmune sobre el crecimiento de carcinomas de endometrio con fenotipo hiper/ultra mutado in vivo.

Piulats Rodriguez, Jose Maria (Investigador principal (IP))

Ref.: PI17/01527

2018-01-01 - 2020-12-31

Unravelling JNK-dependent autophagy networks implicated in targeted therapy resistance in endometrial cancer (EC).

Llobet Navas, David (Participante)

2018-01-01 - 2020-12-31

CARCINOSARCOMA UTERINO. CORRELACIÓN CLÍNICO PATOLÓGICA Y CLASIFICACIÓN MOLECULAR: OPTIMIZANDO EL TRATAMIENTO COMPLEMENTARIO Y DE LA RECIDIVA

Gil Martin, Marta (Investigador principal (IP))

Ref.: BecaInvestigació-APRO-SEOM

Entitat finançadora:
  • ASSOCIACIO PER LA RECERCA ONCOLOGIC

2017-12-01 - 2018-11-30

GEM

Piulats Rodriguez, Jose Maria (Investigador principal (IP))

Ref.: 17CCE006

2017-08-30 - 2018-08-30

Convenio

Piulats Rodriguez, Jose Maria (Investigador principal (IP))

2017-08-30 - 2018-08-30

Analysis of HER2-JAK-STAT3-S100A8/9 axis in breast cancer tissue and Circulating Tumor Cells

Ruth Rodriguez Barrueco (Investigador principal (IP)); Rodriguez Barrueco, Ruth (Investigador/a)

Entitat finançadora:
  • SUSAN CHANNON BREAST CANCER TRUST

2017-08-01 - 2018-07-31

See full list

The role of the tumor suppressor mir-424/503 in dedifferentiation and cancer-ONGOING PROJECT

Llobet Navas, David (Director) Doctorando: Meredith Leigh Davis

2019

Punció ecoguiada i esclerosi amb etanol en el maneig dels quists simples annexials

Ramon Carreras Collado (Director) Doctorando: Marta Castellarnau Visus; PONCE SEBASTIA, JORDI (Director) Doctorando: Marta Castellarnau Visus

2016

Patrones de respuesta a quimioterapia neoadyuvante en càncer de mama y conservación mamaria

Ramon Carreras Collado (Director) Doctorando: Maria Jesús Pla Farnós; PONCE SEBASTIA, JORDI (Director) Doctorando: Maria Jesús Pla Farnós

2016

Determinación del beneficio ofrecido por la Quimioterapia Neoadyuvante en en Cáncer de Ovario avanzado

Collado Contreras, Juan jose (Director) Doctorando: Lola Martí Cardona; PONCE SEBASTIA, JORDI (Director) Doctorando: Lola Martí Cardona

2015

See full list

The group currently has projects under way which are funded by ISCIII, MINECO and private organisations (Merck-Serono, MSD), as well as a good track record of publications in peer-reviewed journals.